Is there a multiplicative adverse effect of cardiovascular and kidney disease on neuropsychological measures?

Edward Helmes1, Truls Østbye, Runa Steenhuis

  • 1a Department of Psychology , James Cook University , Townsville , Queensland , Australia.

Insights

Chronic diseases like cardiovascular and kidney disease may interact, not just add, to impair cognitive function in older adults. This study explored these complex relationships in Canadians aged 65 and older.

Area of Science:

  • Gerontology
  • Neuroscience
  • Public Health

Background:

  • Aging is associated with increased chronic disease incidence and comorbidity.
  • Conditions like cardiovascular disease and kidney disease are linked to cognitive decline.
  • The interaction between multiple chronic diseases and cognition is not fully understood.

Purpose of the Study:

  • To investigate whether the cognitive effects of cardiovascular disease and kidney disease are additive or multiplicative.
  • To examine the impact of co-occurring cardiovascular and kidney disease on cognitive function in older adults.

Main Methods:

  • Analysis of data from 1,782 cognitively healthy Canadians aged 65 and older from the Canadian Study of Health and Aging.
  • Participants were categorized based on the presence of kidney disease, cardiovascular disease, neither, or both.
  • Cognitive performance was assessed, focusing on verbal fluency measures.

Main Results:

  • Verbal fluency scores indicated some predicted interaction effects between diseases.
  • However, the pattern did not show the worst performance in individuals with both conditions as hypothesized.
  • Main effects of disease and significant multiplicative interactions were less pronounced than expected.

Conclusions:

  • The study suggests complex, potentially interactive, relationships between chronic diseases and cognitive function in older adults.
  • Factors like sample characteristics and exclusion criteria may have influenced the observed results.
  • Further research is needed to fully elucidate the interplay between multiple morbidities and cognitive aging.

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
577
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
226
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
348
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
360
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
354
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
387